Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Eye
  • View all journals
  • Search
  • Log in
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. eye
  3. editorials
  4. article
How should active toxoplasmic retinochoroiditis be treated?
Download PDF
Download PDF
  • Editorial
  • Published: 01 November 1997

How should active toxoplasmic retinochoroiditis be treated?

  • John Hay1 &
  • Gordon N Dutton1 

Eye volume 11, pages 767–770 (1997)Cite this article

  • 352 Accesses

  • 3 Citations

  • Metrics details

Article PDF

References

  1. Remington JS, McLeod R, Desmonts G . Toxoplasmosis. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. 4th ed. Philadelphia: WB Saunders, 1996:140–267.

  2. Stanford M . Acute symptomatic Toxoplasma retino-choroiditis. Eye 1996;10:3–4.

    Article  Google Scholar 

  3. McMenamin PG, Dutton GN, Hay J, Cameron S . The ultrastructural pathology of congenital murine toxo-plasmic retinochoroiditis. I. The localization and morphology of Toxoplasma cysts in the retina. Exp Eye Res 1986;43:529–43.

    Article  CAS  Google Scholar 

  4. Beaman MH, Wong S-Y, Remington JS . Cytokines, Toxoplasma and intracellular parasitism. Immunol Rev 1992;127:97–117.

    Article  CAS  Google Scholar 

  5. Holland GN, O'Connor GR, Belford R Jr, Remington JS . Toxoplasmosis. In: Pepose JS, Holland GW, Wilhelmus KR, editors. Ocular infection and immunity. St Louis: Mosby, 1996:1183–223.

  6. Rothova A . Ocular involvement in toxoplasmosis. Br J Ophthalmol 1993;77:371–7.

    Article  CAS  Google Scholar 

  7. Engstrom RE, Holland GN, Nussenblatt RB, Jabs DA . Current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 1991;115:601–10.

    Article  Google Scholar 

  8. McCabe RE, Oster S . Current recommendations and future prospects in the treatment of toxoplasmosis. Drugs 1989;38:973–87.

    Article  CAS  Google Scholar 

  9. Rothova A, Meenken C, Buitenhuis HJ, Brinkman CJ, Baarsma GS, Boen-Tan TN, de Jong PTVM, Khaas-sen-Brockema N, Schweitzer CMC, Timmerman Z, de Vries J, Zaal MJW, Kiljstra A . Therapy for ocular toxoplasmosis. Am J Ophthalmol 1993;115:517–23.

    Article  CAS  Google Scholar 

  10. Mets MB, Holfels E, Boyer KM, Swisher CN, Roizen N, Stein L, Hopkins J, Withers S, Mack D, Luciano R, Patel D, Remington JS, Meier P, McLeod R . Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 1996;122:309–24.

    Article  CAS  Google Scholar 

  11. Cochereau-Massin I, Le Hoang P, Lautier-Frau M, Zerdoun E, Zazoun L, Robinet M, Marcel P, Girard B, Katlama C, Leport C, Rozenbaum W, Coulaud JP, Gentilini M . Ocular toxoplasmosis in human immunodeficiency virus-infected patients. Am J Ophthalmol 1992;114:130–5.

    Article  CAS  Google Scholar 

  12. Holland GN, Engstrom RE Jr, Glasgow BJ, Beuger BB, Daniels SA, Sidikaro Y, Harmon JA, Fischer DH, Boyer DS, Rao NA, Eagle RC Jr, Kreiger AE, Foos RY . Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 1988;106:653–67.

    Article  CAS  Google Scholar 

  13. Sande MA, Whitley RJ, McCracken GH, Lentnek A, Scheld WM . Evaluation of new anti-infective drugs for the treatment of Toxoplasma encephalitis. Clin Infect Dis 1992;15(Suppl 1);S200–5.

    Article  Google Scholar 

  14. Suzuki Y, Yang Q, Conley FK, Abrams JS, Remington JS . Antibody against interleukin-6 reduces inflammation and numbers of cysts in brains of mice with toxoplasmic encephalitis. Infect Immunol 1994;62:2773–8.

    CAS  Google Scholar 

  15. Hunter CA, Subauste CS, Remington JS . The role of cytokines in toxoplasmosis. Biotherapy 1994;7:237–47.

    Article  CAS  Google Scholar 

  16. Gazzinelli RT, Brezin A, Li Q, Nussenblatt RB, Chan C-C . Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF-α and IFN-γ. Exp Parasitol 1994;78:217–29.

    Article  CAS  Google Scholar 

  17. Cesario TC, Slater LM, Kaplan HS . Effect of anti-neoplastic agents on gamma-interferon production in human peripheral blood mononuclear cells. Cancer Res 1984;44:4962–6.

    CAS  PubMed  Google Scholar 

  18. Leake J . Thousands fight for steroid justice. The Sunday Times, 27 August 1995.

  19. Acers TE . Toxoplasmic retinochoroiditis: a double blind therapeutic study. Arch Ophthalmol 1964;71:58–62.

    Article  CAS  Google Scholar 

  20. O'Connor GR, Frenkel JK . Dangers of steroid therapy in toxoplasmosis. Arch Ophthalmol 1976;94:213–6.

    Article  CAS  Google Scholar 

  21. Dubremetz JF . Toxoplasma gondii: cell biology update. In: Boothroyd JC, Komuniecki R, editors. Molecular approaches to parasitology. New York: Wiley, 1995:345–58.

  22. Tomavo S, Boothroyd JC . Interconnection between organellar functions, development and drug resistance in the protozoan parasite, Toxoplasma gondii. Int J Parasitol 1995;25:1293–9.

    Article  CAS  Google Scholar 

  23. James SL . Role of nitric oxide in parasitic infections. Microbiol Rev 1995;59:533–47.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Sibley LD, Howe DK . Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis 1995;172:1561–6.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tennent Institute of Ophthalmology Western Infirmary, Glasgow, UK

    John Hay & Gordon N Dutton

Authors
  1. John Hay
    View author publications

    Search author on:PubMed Google Scholar

  2. Gordon N Dutton
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hay, J., Dutton, G. How should active toxoplasmic retinochoroiditis be treated?. Eye 11, 767–770 (1997). https://doi.org/10.1038/eye.1997.202

Download citation

  • Issue date: 01 November 1997

  • DOI: https://doi.org/10.1038/eye.1997.202

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Follow us on Twitter
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information
  • Open Access Fees and Funding
  • About the Editors
  • Journal News
  • Special Issues
  • About the Partner
  • EYE Covers
  • Contact
  • For Advertisers
  • Subscribe

Publish with us

  • For Authors & Referees
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Eye (Eye)

ISSN 1476-5454 (online)

ISSN 0950-222X (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited